With 32% Ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Insiders Have a Lot Riding on the Company's Future

Yahoo FinanceDec 9, 2024 23:27

Nautilus Biotechnology Price Target Cut to $1.75/Share From $2.25 by Goldman Sachs

Dow JonesDec 6, 2024 01:52 · Ratings

Nautilus Biotechnology Analyst Ratings

BenzingaDec 6, 2024 01:41 · Ratings

Goldman Sachs Downgrades Nautilus Biotechnology(NAUT.US) to Sell Rating

Futu NewsDec 6, 2024 01:35 · Ratings

Goldman Sachs Downgrades Nautilus Biotechnolgy to Sell From Neutral

MT NewswiresDec 5, 2024 21:40

Nautilus Biotechnology Insiders Lose Out As Stock Sinks To US$2.47

Simply Wall StNov 14, 2024 18:06